Onesource Specialty Pharma Limited has informed the Exchange about Disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 and Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015.Promoter group entities have purchased additional 443,906 equity shares of OneSource Specialty Pharma Limited, between January 30, 2026 and February 04, 2026.
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Onesource Specialty Pharma Limited informed the stock exchange that promoter group entities bought 443,906 additional equity shares of the company during the period from January 30, 2026 to February 04, 2026. The disclosure was filed under SEBI's Takeover Regulations (Regulation 29(2)) and Insider Trading Regulations (Regulation 7(2)), which require promoters to report share acquisitions exceeding certain thresholds. This signals continued promoter confidence in the company's prospects. The purchase indicates the promoter group is increasing its stake in the pharmaceutical company.
This is a positive signal for retail investors as promoter buying often reflects management's confidence in the company's future performance. The stock may see positive sentiment, though the impact on price depends on the size of the purchase relative to total share volume.